Success Metrics

Clinical Success Rate

75.0%

Based on 3 completed trials

Completion Rate

75%(3/4)

Active Trials

0(0%)

Results Posted

67%(2 trials)

Terminated

1(20%)

Phase Distribution

Ph early_phase_1

20%

Ph not_applicable

40%

Ph phase_1

20%

Ph phase_4

20%

Phase Distribution

Early Stage

Mid Stage

Late Stage

Phase Distribution5 total trials

Early Phase 1First-in-human

1(20.0%)

Phase 1Safety & dosage

1(20.0%)

Phase 4Post-market surveillance

1(20.0%)

N/ANon-phased studies

2(40.0%)

Highest Phase Reached

Phase 4

Trial Status & Enrollment

Completion Rate

60.0%

3 of 5 finished

Non-Completion Rate

40.0%

2 ended early

Currently Active

trials recruiting

Total Trials

all time

Status Distribution

Completed(3)

Terminated(2)

Detailed Status

Completed3

Terminated1

Withdrawn1

Development Timeline

Analytics

Development Status

Total Trials

Active

Success Rate

75.0%

Most Advanced

Phase 4

Trials by Phase

Early Phase 11 (20.0%)

Phase 11 (20.0%)

Phase 41 (20.0%)

N/A2 (40.0%)

Trials by Status

terminated120%

withdrawn120%

completed360%

Recent Activity

0 active trials

Showing 5 of 5

withdrawnphase_1

QUILT-3.051: NANT Ovarian Cancer Vaccine: Combination Immunotherapy in Subjects With Epithelial Ovarian Cancer Who Have Progressed on or After Standard-of-care (SoC) Therapy

NCT03197584

completedphase_4

Niacin, N-3 Fatty Acids and Insulin Resistance

NCT00286234

completednot_applicable

The Effect of Phytosterol Esters of Omega-3 (Vayarol) Versus Omega-3 Acids Ethyl Esters in Reducing Triglyceride Levels

NCT01712867

terminatednot_applicable

Feasibility Study of Omega-3 Fatty Acids in Dialysis Patients

NCT01002118

completedearly_phase_1

Effects of Omacor and Aspirin on Platelet Function

NCT00688961

Clinical Trials (5)

Showing 5 of 5 trials

NCT03197584Phase 1

QUILT-3.051: NANT Ovarian Cancer Vaccine: Combination Immunotherapy in Subjects With Epithelial Ovarian Cancer Who Have Progressed on or After Standard-of-care (SoC) Therapy

Withdrawn

NCT00286234Phase 4

Niacin, N-3 Fatty Acids and Insulin Resistance

Completed

NCT01712867Not Applicable

The Effect of Phytosterol Esters of Omega-3 (Vayarol) Versus Omega-3 Acids Ethyl Esters in Reducing Triglyceride Levels

Completed

NCT01002118Not Applicable

Feasibility Study of Omega-3 Fatty Acids in Dialysis Patients

Terminated

NCT00688961Early Phase 1

Effects of Omacor and Aspirin on Platelet Function

Completed

All 5 trials loaded

Drug Details

Intervention Type: DRUG
Total Trials: 5